Wendy McDermott Biography and Net Worth

Senior Vice President, Human Resources of Lexicon Pharmaceuticals

Wendy E. McDermott has been our senior vice president of human resources since 2024 and our vice president of human resources since 2022. Ms. McDermott previously served as chief people officer of Rafael Pharmaceuticals, Inc. since 2019, vice president, human resources of Sanofi from 2017 to 2019 and in a variety of human resources positions with Sanofi, Schering-Plough Corporation and other companies in the tobacco, media and talent and event management industries. Ms. McDermott received her B.A. from State University of New York at Plattsburgh.

What is Wendy McDermott's net worth?: The estimated net worth of Wendy McDermott is at least $40.44 thousand as of August 4th, 2023. Ms. McDermott owns 28,478 shares of Lexicon Pharmaceuticals stock worth more than $40,439 as of December 5th. This net worth evaluation does not reflect any other assets that Ms. McDermott may own. Learn More about Wendy McDermott's net worth.
How do I contact Wendy McDermott?: The corporate mailing address for Ms. McDermott and other Lexicon Pharmaceuticals executives is 8800 TECHNOLOGY FOREST PLACE, THE WOODLANDS TX, 77381. Lexicon Pharmaceuticals can also be reached via phone at (281) 863-3000 and via email at [email protected]. Learn More on Wendy McDermott's contact information.
Has Wendy McDermott been buying or selling shares of Lexicon Pharmaceuticals?: Wendy McDermott has not been actively trading shares of Lexicon Pharmaceuticals within the last three months. Most recently, on Friday, August 4th, Wendy Mcdermott bought 6,000 shares of Lexicon Pharmaceuticals stock. The stock was acquired at an average cost of $1.84 per share, with a total value of $11,040.00. Following the completion of the transaction, the vice president now directly owns 28,478 shares of the company's stock, valued at $52,399.52. Learn More on Wendy McDermott's trading history.

Wendy McDermott Insider Trading History at Lexicon Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/4/2023	Buy	6,000	$1.84	$11,040.00	28,478
6/23/2023	Buy	10,000	$2.43	$24,300.00	22,478

Wendy McDermott Buying and Selling Activity at Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Company Overview

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Today's Range

Now: $1.42

$1.38

$1.43

50 Day Range

MA: $1.42

$1.25

$1.64

2 Week Range

Now: $1.42

$0.28

$1.66

Volume

1,437,782 shs

Average Volume

2,003,313 shs

Market Capitalization

$516.03 million

P/E Ratio

N/A

Dividend Yield